BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 2016;22 Suppl 2:S27-36. [PMID: 27125562 DOI: 10.1016/S1198-743X(16)30095-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 34] [Article Influence: 20.8] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez PL, Rappo U, Akinapelli K, McGregor JS, Puttagunta S, Dunne MW. Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs. Drugs Context 2018;7:212559. [PMID: 30574170 DOI: 10.7573/dic.212559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Golan Y. Current Treatment Options for Acute Skin and Skin-structure Infections. Clin Infect Dis 2019;68:S206-12. [PMID: 30957166 DOI: 10.1093/cid/ciz004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
3 Al-Jumaili A, Kumar A, Bazaka K, Jacob MV. Plant Secondary Metabolite-Derived Polymers: A Potential Approach to Develop Antimicrobial Films. Polymers (Basel) 2018;10:E515. [PMID: 30966549 DOI: 10.3390/polym10050515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ziesmer J, Tajpara P, Hempel NJ, Ehrström M, Melican K, Eidsmo L, Sotiriou GA. Vancomycin-Loaded Microneedle Arrays against Methicillin-Resistant Staphylococcus Aureus Skin Infections. Adv Mater Technol 2021;6:2001307. [PMID: 34307835 DOI: 10.1002/admt.202001307] [Reference Citation Analysis]
5 Haq A, Kumar S, Mao Y, Berthiaume F, Michniak-Kohn B. Thymoquinone-Loaded Polymeric Films and Hydrogels for Bacterial Disinfection and Wound Healing. Biomedicines 2020;8:E386. [PMID: 32998437 DOI: 10.3390/biomedicines8100386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Emene CC, Kravchenko IE, Aibatova GI, Rizvanov AA. Analysis of Serum Cytokines and Single-Nucleotide Polymorphisms of SOD1, SOD2, and CAT in Erysipelas Patients. J Immunol Res 2017;2017:2157247. [PMID: 28512644 DOI: 10.1155/2017/2157247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Shortridge D, Flamm RK. Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections. Clinical Infectious Diseases 2019;68:S200-5. [DOI: 10.1093/cid/ciz003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sun M, Zhu C, Long J, Lu C, Pan X, Wu C. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections. Drug Deliv 2020;27:632-41. [PMID: 32329376 DOI: 10.1080/10717544.2020.1756985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
9 Restelli U, Bonfanti M, Croce D, Grau S, Metallidis S, Moreno Guillén S, Pacelli V, Rizzardini G, Soro M, Vozikis A, Gray A. Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis. BMJ Open 2019;9:e031356. [PMID: 31515433 DOI: 10.1136/bmjopen-2019-031356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wittke F, Vincent C, Chen J, Heller B, Kabler H, Overcash JS, Leylavergne F, Dieppois G. Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid. Antimicrob Agents Chemother 2020;64:e00250-20. [PMID: 32747361 DOI: 10.1128/AAC.00250-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
11 Pullman J, Gardovskis J, Farley B, Sun E, Quintas M, Lawrence L, Ling R, Cammarata S; PROCEED Study Group. Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study. J Antimicrob Chemother 2017;72:3471-80. [PMID: 29029278 DOI: 10.1093/jac/dkx329] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 15.7] [Reference Citation Analysis]
12 Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infect Drug Resist 2018;11:1959-74. [PMID: 30464538 DOI: 10.2147/IDR.S172366] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 8.7] [Reference Citation Analysis]
13 Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis 2019;68:S193-9. [PMID: 30957165 DOI: 10.1093/cid/ciz002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 32.0] [Reference Citation Analysis]
14 Sandoe JAT, Saeed K, Guleri A, Hand KS, Dillon R, Allen M, Mayes A, Glen F, Gonzalez-Ruiz A. Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study. Ther Adv Infect Dis 2019;6:2049936118823655. [PMID: 30783523 DOI: 10.1177/2049936118823655] [Reference Citation Analysis]
15 Bridgman AC, Fitzmaurice C, Dellavalle RP, Karimkhani Aksut C, Grada A, Naghavi M, Manafi N, Olagunju AT, Olagunju TO, Somayaji R, Drucker AM. Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study [Formula: see text]. J Cutan Med Surg 2020;24:161-73. [PMID: 31994902 DOI: 10.1177/1203475420902047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Tanvir SB, Qasim SSB, Latimer J, Qamar Z, Niazi FH. The Efficacy and Adverse Events of Delafloxacin for Treating Acute Bacterial Skin and Skin Structure Infections: A Systematic Review and Meta-Analysis. J Pharm Bioallied Sci 2020;12:S538-45. [PMID: 33149517 DOI: 10.4103/jpbs.JPBS_154_20] [Reference Citation Analysis]
17 Thy M, Tanaka S, Tran-Dinh A, Ribeiro L, Lortat-Jacob B, Donadio J, Zappella N, Ben-Rehouma M, Tashk P, Snauwaert A, Atchade E, Grall N, Montravers P. Dynamic Changes in Microbial Composition During Necrotizing Soft-Tissue Infections in ICU Patients. Front Med (Lausanne) 2020;7:609497. [PMID: 33748150 DOI: 10.3389/fmed.2020.609497] [Reference Citation Analysis]
18 Lagi F, Ottino L, Mantengoli E, Distefano A, Corti G, Farese A, Dannaoui B, Ipponi A, Falai T, Rossolini GM, Bartoloni A, Bartalesi F. Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy. Eur J Clin Microbiol Infect Dis 2019;38:1781-5. [PMID: 31222396 DOI: 10.1007/s10096-019-03609-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kane TL, Carothers KE, Lee SW. Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics. Curr Drug Targets 2018;19:111-27. [PMID: 27894236 DOI: 10.2174/1389450117666161128123536] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
20 Vlachaki I, Vacchelli M, Zinzi D, Falla E, Jiang Y, Mantopoulos T, Nathwani D. Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis. BMC Infect Dis 2021;21:1036. [PMID: 34610820 DOI: 10.1186/s12879-021-06736-x] [Reference Citation Analysis]
21 Kyei-Baffour K, Mohammad H, Seleem MN, Dai M. Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus. Bioorg Med Chem 2019;27:1845-54. [PMID: 30926310 DOI: 10.1016/j.bmc.2019.03.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Stargardt T, Eckmann C, Bouza E, Rossolini GM, Grossi PA. Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey. Eur J Clin Microbiol Infect Dis 2018;37:1611-8. [PMID: 29876772 DOI: 10.1007/s10096-018-3264-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Simonetti O, Lucarini G, Morroni G, Orlando F, Lazzarini R, Zizzi A, Brescini L, Provinciali M, Giacometti A, Offidani A, Cirioni O. New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection. Antimicrob Agents Chemother 2020;64:e02062-19. [PMID: 31932371 DOI: 10.1128/AAC.02062-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Mohammad H, Kyei-Baffour K, Abutaleb NS, Dai M, Seleem MN. An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection. J Glob Antimicrob Resist 2019;19:1-7. [PMID: 31051286 DOI: 10.1016/j.jgar.2019.04.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 O'Riordan W, McManus A, Teras J, Poromanski I, Cruz-Saldariagga M, Quintas M, Lawrence L, Liang S, Cammarata S; PROCEED Study Group. A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study. Clin Infect Dis 2018;67:657-66. [PMID: 29518178 DOI: 10.1093/cid/ciy165] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 20.0] [Reference Citation Analysis]
26 Bookstaver PB, Jenkins TC, Stenehjem E, Doron S, Brown J, Goldwater SH, Lopes C, Haynes A, Udeze C, Mo Y, Gillard P, Liu Y, Keyloun K. Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments. Open Forum Infect Dis 2018;5:ofy109. [PMID: 30581883 DOI: 10.1093/ofid/ofy109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Pérez-Laguna V, García-Luque I, Ballesta S, Rezusta A, Gilaberte Y. Photodynamic Therapy Combined with Antibiotics or Antifungals against Microorganisms That Cause Skin and Soft Tissue Infections: A Planktonic and Biofilm Approach to Overcome Resistances. Pharmaceuticals (Basel) 2021;14:603. [PMID: 34201530 DOI: 10.3390/ph14070603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Gallagher JC. Omadacycline: A Modernized Tetracycline. Clin Infect Dis 2019;69:S1-5. [PMID: 31367739 DOI: 10.1093/cid/ciz394] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
29 Agarwal R, Bartsch SM, Kelly BJ, Prewitt M, Liu Y, Chen Y, Umscheid CA. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect 2018;24:361-8. [PMID: 28882727 DOI: 10.1016/j.cmi.2017.08.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
30 Taofiq O, Heleno SA, Calhelha RC, Alves MJ, Barros L, Barreiro MF, González-Paramás AM, Ferreira IC. Development of Mushroom-Based Cosmeceutical Formulations with Anti-Inflammatory, Anti-Tyrosinase, Antioxidant, and Antibacterial Properties. Molecules 2016;21:E1372. [PMID: 27754433 DOI: 10.3390/molecules21101372] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
31 Ribeiro DML, Carvalho Júnior AR, Vale de Macedo GHR, Chagas VL, Silva LDS, Cutrim BDS, Santos DM, Soares BLL, Zagmignan A, de Miranda RCM, de Albuquerque PBS, Nascimento da Silva LC. Polysaccharide-Based Formulations for Healing of Skin-Related Wound Infections: Lessons from Animal Models and Clinical Trials. Biomolecules 2019;10:E63. [PMID: 31905975 DOI: 10.3390/biom10010063] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
32 Scangarella-Oman NE, Ingraham KA, Tiffany CA, Tomsho L, Van Horn SF, Mayhew DN, Perry CR, Ashton TC, Dumont EF, Huang J, Brown JR, Miller LA. In Vitro Activity and Microbiological Efficacy of Gepotidacin from a Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients with Acute Bacterial Skin and Skin Structure Infections. Antimicrob Agents Chemother 2020;64:e01302-19. [PMID: 31818823 DOI: 10.1128/AAC.01302-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
33 Tulkens PM, Van Bambeke F, Zinner SH. Profile of a Novel Anionic Fluoroquinolone-Delafloxacin. Clin Infect Dis 2019;68:S213-22. [PMID: 30957164 DOI: 10.1093/cid/ciy1079] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
34 Hsueh YH, Tsai PH, Lin KS. pH-Dependent Antimicrobial Properties of Copper Oxide Nanoparticles in Staphylococcus aureus. Int J Mol Sci 2017;18:E793. [PMID: 28397766 DOI: 10.3390/ijms18040793] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]